Integral Derivatives’s Baker Hughes BHI Stock Holding History

Integral Derivatives’s Portfolio BHI Stock Details BHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-25,397	Closed	-$1.51M	–	1340
2016 Q3	$1.28M	Buy	25,397 +1,797	+8%	+$86.5K	0.03%	371
2016 Q2	$1.06M	Buy	23,600 +10,505	+80%	+$476K	0.03%	397
2016 Q1	$574K	Buy	+13,095	New	+$566K	0.02%	498
2015 Q1	–	Sell	-21,577	Closed	-$1.3M	–	1532
2014 Q4	$1.21M	Sell	21,577 -4,550	-17%	-$257K	0.02%	603
2014 Q3	$1.7M	Buy	+26,127	New	+$1.82M	0.03%	535

Other funds holding BHI

AIM

Artemis Investment Management Edinburgh, United Kingdom $9.43B AUM 69.06% 1-Year Est. Return

LHC

Levy Harkins & Co New York $393M AUM 26.94% 1-Year Est. Return

GIBU

Gulf International Bank (UK) London, United Kingdom $4.47B AUM 29.35% 1-Year Est. Return

SBA

Seven Bridges Advisors New York $9.75M AUM 16.73% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

TCA

Tortoise Capital Advisors Overland Park, Kansas $9.6B AUM 19.53% 1-Year Est. Return

Integral Derivatives's BHI Position: Q4 2016 in Review

Integral Derivatives sold out of Baker Hughes (BHI) in Q4 2016, closing a stake of 25,397 shares — an estimated $1.51M sold.

Integral Derivatives first reported a position in BHI in Q3 2014 and held it in 5 quarters. The position peaked at $1.7M in Q3 2014. 673 funds tracked by Wall St. Rank hold BHI as of Q4 2016.

Integral Derivatives reported no remaining Baker Hughes position as of Q4 2016 after selling out during the quarter.
Integral Derivatives sold 25,397 Baker Hughes shares in Q4 2016, an estimated $1.51M.
Integral Derivatives first reported a position in Baker Hughes in Q3 2014 and held it in 5 quarters.
Integral Derivatives's Baker Hughes position peaked at $1.7M in Q3 2014.
673 funds tracked by Wall St. Rank held Baker Hughes as of Q4 2016.

Based on Integral Derivatives's 13F filing for Q4 2016, filed 14 Feb 2017.